DSC
Duncker Streett & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.44M | Sell |
7,732
-15
| -0.2% | -$6.68K | 0.63% | 39 |
|
|
2025
Q1 | $3.76M | Buy |
7,747
+84
| +1% | +$40.7K | 0.74% | 35 |
|
|
2024
Q4 | $3.09M | Buy |
7,663
+335
| +5% | +$135K | 0.57% | 49 |
|
|
2024
Q3 | $3.41M | Buy |
7,328
+903
| +14% | +$420K | 0.62% | 46 |
|
|
2024
Q2 | $3.01M | Buy |
+6,425
| New | +$3.01M | 0.58% | 52 |
|
|
2020
Q4 | – | Sell |
-200
| Closed | -$54K | – | 563 |
|
|
2020
Q3 | $54K | Buy |
200
+50
| +33% | +$13.5K | 0.01% | 317 |
|
|
2020
Q2 | $44K | Buy |
+150
| New | +$44K | 0.01% | 330 |
|
|
2019
Q2 | – | Sell |
-300
| Closed | -$55K | – | 579 |
|
|
2019
Q1 | $55K | Buy |
+300
| New | +$55K | 0.01% | 365 |
|